SFS
GILD icon

Sunrise Financial Services’s Gilead Sciences GILD Stock Holding History

Sunrise Financial Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.54K Sell
28
-5
-15% -$659 ﹤0.01% 320
2026
Q1 		$4.6K Buy
33
+6
+22% +$840 ﹤0.01% 295
2025
Q4 		$3.31K Buy
+27
New +$3.28K ﹤0.01% 295

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sunrise Financial Services's GILD Position: Q2 2026 in Review

Sunrise Financial Services reduced its Gilead Sciences (GILD) stake by 15% in Q2 2026, selling an estimated $659 and leaving 28 shares worth $3.54K. The position accounts for ﹤0.01% of the portfolio, ranked #320.

Sunrise Financial Services first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.6K in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sunrise Financial Services held 28 shares of Gilead Sciences worth $3.54K as of Q2 2026.
  • Sunrise Financial Services sold 5 Gilead Sciences shares in Q2 2026, an estimated $659.
  • Gilead Sciences made up ﹤0.01% of Sunrise Financial Services's portfolio in Q2 2026, its #320 holding.
  • Sunrise Financial Services first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Sunrise Financial Services's Gilead Sciences position peaked at $4.6K in Q1 2026.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sunrise Financial Services's 13F filing for Q2 2026, filed 12 Aug 2026.